SCHEMBL14730207

SCHEMBL14730207

CN(C(=O)c1cnc(N2C[C@H](NC(=O)OC(C)(C)C)[C@@H](c3cc(F)ccc3F)C2)nc1)C1CCN(c2nc([C@@H]3CCCO3)no2)CC1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 5/20 0.34
VNN1 O95497 3/20 0.32
HDAC4 P56524 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HTR2A P28223 1/20 0.31
DRD3 P35462 1/20 0.31
EIF2AK4 Q9P2K8 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
WDR5 P61964 1/20 0.31
F2R P25116 1/20 0.31
ACKR3 P25106 1/20 0.30
NR1H2 P55055 2/20 0.30
NR1H3 Q13133 1/20 0.30
BRAF P15056 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730312 0.91 GPR119 (0.36) NTRK1VNN1HDAC4HDAC6HTR2A
SCHEMBL14730202 0.88 NTRK1 (0.35) NTRK1VNN1HDAC4HDAC6EIF2AK4
SCHEMBL14730255 0.88 PDK2 (0.34)
SCHEMBL14730252 0.88 GPR119 (0.37) NTRK1VNN1HDAC4HDAC6EIF2AK4
SCHEMBL14730205 0.87 NTRK1 (0.34) NTRK1VNN1HDAC4HDAC6HTR2A
SCHEMBL14730263 0.87 GPR119 (0.35) NTRK1VNN1HDAC4HDAC6EIF2AK4
SCHEMBL14730289 0.86 MCHR1 (0.34) NTRK1VNN1HTR2ADRD3MEN1
SCHEMBL14730179 0.85 GPR119 (0.34) NTRK1HTR2ADRD3NR1H2
SCHEMBL14730276 0.85
SCHEMBL14730227 0.84 NTRK1 (0.34) NTRK1HTR2ADRD3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed